|

atumelnant Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Crinetics Pharmaceuticals Inc.1

Indications

  • Ectopic ACTH Syndrome1
  • Cushing Disease1
  • Cushing Syndrome1
  • Cancer1

Bethesda, Maryland1 trial

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.